STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.

RJ, Barst; M, Beghetti; T, Pulido; G, Layton; I, Konourina; M, Zhang; DD, Ivy

doi:10.1161/circulationaha.113.005698

Public

STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.

Shared by NobleBlocks on Mar 17, 2014 • 12:00 AM UTC

Authors:

Barst RJ

Beghetti M

Pulido T

Abstract

<h4>Background</h4>The double-blind, placebo-controlled Sildenafil in Treatment-Naive Children, Aged 1 to 17 Years, With Pulmonary Arterial Hypertension (STARTS-1) study assessed sildenafil in pediatric patients with pulmonary arterial hypertension; improved hemodynamics and exercise capacity occurr...

Subject

Survival

Pulmonary hypertension

Pediatrics

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!